Histological characteristics and prognosis in patients with fatty liver

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 4, 2005, Pages 460-467

  Dam Larsen, Sanne ^a   Franzmann, Maria Benedicte ^a   Christoffersen, Per ^a   Larsen, Klaus ^a   Becker, Ulrik ^a   Bendtsen, Flemming ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alcoholic; Cirrhosis; Epidemiology; Fatty liver; Histology; Mortality; Non alcoholic; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; STEATOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 17444364144     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510012217     Document Type: Article

References (29)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
2. Lonardo A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig Dis Sci 1999;17:80-9.
3. Hilden M, Christoffersen P, Juhl E, Dalgaard JB. Liver histology in a "normal" population: examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977;12:593-7.
4. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002;50:585-8.
5. Baddeley RM. An epilogue to jejunoileal bypass. World J Surg 1985;9:842-9.
6. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121: 91-100.
7. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998; 15:246-58.
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
9. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95: 1056-62.
10. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-8.
11. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9.
12. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
13. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity [comments]. Gastroenterology 1994;107:1103-9.
14. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-23.
15. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
16. Sorensen TIA, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;2:241-4.
17. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
18. International Center for Disease Classification. International classification of diseases, 8th revision (ICD-8). Geneva: World Health Organisation; 1974.
19. International Center for Disease Classification. International classification of diseases, 10th revision (ICD-10). Geneva: World Health Organisation; 1994.
20. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999;46:354-7.
21. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, et al. Long-term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53:750-5.
22. Vestberg K, Thulstrup AM, Sorensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst 1997;21:11-20.
23. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001;164:33-7.
24. Becker U, Deis A, Sorensen TIA, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23:1025-9.
25. Weis N, Krogsgaard K, Kjærgaard LL, et al. Kronisk hepatitis C. Kombinationsbehandling med alfa-interferon og ribavirin. Med Teknologivurdering-puljeprojekter 2002; 2:47-55.
26. Wantzin PS, Krogsgaard K, Dickmeiss E. Screening of Danish blood donors for hepatitis C virus antibodies. Ugeskr Laeger 1990;152:2846-8.
27. Orholm M, Sorensen TIA, Bentsen K, Hoybye G, Eghoje K, Christoffersen P. Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury. Liver 1985;5:253-60.
28. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver [comments]. Lancet 1995;346: 987-90.
29. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-7.